These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25332033)

  • 1. Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia.
    Hocking C; Broadbridge VT; Karapetis C; Beeke C; Padbury R; Maddern GJ; Roder DM; Price TJ
    Med J Aust; 2014 Oct; 201(8):462-6. PubMed ID: 25332033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry.
    Tomita Y; Karapetis CS; Roder D; Beeke C; Hocking C; Roy AC; Townsend AR; Padbury R; Maddern G; Price TJ
    Aust J Rural Health; 2016 Apr; 24(2):85-91. PubMed ID: 26255652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
    Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
    Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
    Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
    J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of travel distance on access to treatment and survival in patients with metastatic colorectal cancer prescribed bevacizumab plus chemotherapy.
    Payette E; Sarker S; Chalchal H
    Can J Rural Med; 2017; 22(4):148-152. PubMed ID: 28925914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.
    Roder D; Karapetis CS; Wattchow D; Moore J; Singhal N; Joshi R; Keefe D; Fusco K; Powell K; Eckert M; Price TJ
    Asian Pac J Cancer Prev; 2015; 16(6):2431-40. PubMed ID: 25824777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
    Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
    Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.
    Vatandoust S; Price TJ; Ullah S; Roy AC; Beeke C; Young JP; Townsend A; Padbury R; Roder D; Karapetis CS
    Clin Colorectal Cancer; 2016 Mar; 15(1):32-6. PubMed ID: 26341410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rural populations have equal surgical and survival outcomes in metastatic colorectal cancer.
    Singla A; Broadbridge V; Mittinty M; Beeke C; Maddern GJ
    Aust J Rural Health; 2014 Oct; 22(5):249-56. PubMed ID: 25303417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.
    Turner NH; Wong HL; Field K; Wong R; Shapiro J; Yip D; Nott L; Tie J; Kosmider S; Tran B; Desai J; McKendrick J; Zimet A; Richardson G; Iddawela M; Gibbs P
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):262-71. PubMed ID: 25871458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?
    Price TJ; Beeke C; Townsend AR; Lo L; Amitesh R; Padbury R; Roder D; Maddern G; Moore J; Karapetis C
    Mol Diagn Ther; 2016 Feb; 20(1):75-82. PubMed ID: 26714964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
    Vijayvergia N; Li T; Wong YN; Hall MJ; Cohen SJ; Dotan E
    Cancer; 2016 Oct; 122(20):3191-3198. PubMed ID: 27379436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades.
    Roder D; Karapetis CS; Wattchow D; Moore J; Singhal N; Joshi R; Keefe D; Fusco K; Buranyi-Trevarton D; Sharplin G; Price TJ
    Asian Pac J Cancer Prev; 2015; 16(14):5923-31. PubMed ID: 26320474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Patel D; Townsend AR; Karapetis C; Beeke C; Padbury R; Roy A; Maddern G; Roder D; Price TJ
    Ann Surg Oncol; 2016 Oct; 23(11):3616-3622. PubMed ID: 27251133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.
    Reynolds J; Chamberland-Tremblay A; Herrington JD; Munoz Maldonado Y; Wong L
    J Oncol Pharm Pract; 2017 Apr; 23(3):173-178. PubMed ID: 26786027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: results from the South Australian Metastatic Colorectal Cancer Registry.
    McNeill D; Karapetis CS; Price TJ; Meagher P; Piantadosi C; Quinn S; Roder D; Padbury R; Maddern G; Townsend A; Jayawardana MW; Roy AC
    Intern Med J; 2021 Jan; 51(1):69-77. PubMed ID: 31985128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Wang EN; Maeda K; Hirakawa K; Ohira M
    Anticancer Res; 2019 Feb; 39(2):1051-1057. PubMed ID: 30711994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship Between Health-Related Quality of Life and Survival in Metastatic Colorectal Cancer Patients Treated With Korean Medicine.
    Park S; Eo W; Lee S
    Integr Cancer Ther; 2018 Mar; 17(1):65-72. PubMed ID: 28024424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.